GIM
Granahan Investment Management Portfolio holdings
AUM
$2.46B
This Quarter Return
+8.86%
1 Year Return
+66.36%
3 Year Return
+183.04%
5 Year Return
+309.49%
10 Year Return
+1,968.52%
AUM
$2.85B
AUM Growth
+$2.85B
(-5.9%)
Cap. Flow
-$275M
Cap. Flow
% of AUM
-9.66%
Top 10 Holdings %
Top 10 Hldgs %
28.66%
Holding
200
New
20
Increased
52
Reduced
108
Closed
19
Top Buys
| 1 |
indie Semiconductor
INDI
|
$43.8M |
| 2 |
Viking Therapeutics
VKTX
|
$26.1M |
| 3 |
Vivid Seats
SEAT
|
$21.3M |
| 4 |
Shift4
FOUR
|
$20.3M |
| 5 |
Carpenter Technology
CRS
|
$19.9M |
Top Sells
| 1 |
Axon Enterprise
AXON
|
$30.9M |
| 2 |
HubSpot
HUBS
|
$28.6M |
| 3 |
Paylocity
PCTY
|
$24M |
| 4 |
Kinsale Capital Group
KNSL
|
$23M |
| 5 |
Toast
TOST
|
$21.2M |
Sector Composition
| 1 | Technology | 42.38% |
| 2 | Healthcare | 19.93% |
| 3 | Industrials | 12.18% |
| 4 | Consumer Discretionary | 7.7% |
| 5 | Communication Services | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Enovix
ENVX
$1.79B
| $5.63M | 0.2% |
803,854
-994,479
| -55% | -$6.97M |
|
127
Arcus Biosciences
RCUS
$1.24B
| $5.6M | 0.2% |
296,570
+65,793
| +29% | +$1.24M |
|
128
Neogen
NEOG
$1.24B
| $5.07M | 0.18% |
321,044
+33,689
| +12% | +$532K |
|
129
Sprinklr
CXM
$2B
| $4.39M | 0.15% |
357,656
-66,334
| -16% | -$814K |
|
130
Shoals Technologies Group
SHLS
$1.13B
| $4.3M | 0.15% |
384,724
+90,302
| +31% | +$1.01M |
|
131
Canadian Solar
CSIQ
$663M
| $4.21M | 0.15% |
213,016
-66,183
| -24% | -$1.31M |
|
132
Allegro MicroSystems
ALGM
$5.52B
| $4.21M | 0.15% |
+155,980
| New | +$4.21M |
|
133
Certara
CERT
$1.69B
| $4.1M | 0.14% |
229,150
-14,404
| -6% | -$258K |
|
134
Guardant Health
GH
$8.11B
| $4.09M | 0.14% |
+198,434
| New | +$4.09M |
|
135
Rapid7
RPD
$1.32B
| $3.95M | 0.14% |
80,612
-11,249
| -12% | -$552K |
|
136
Riskified
RSKD
$712M
| $3.94M | 0.14% |
729,153
-1,498,032
| -67% | -$8.1M |
|
137
Arteris
AIP
$377M
| $3.93M | 0.14% |
536,263
-232,956
| -30% | -$1.71M |
|
138
Apellis Pharmaceuticals
APLS
$3.51B
| $3.91M | 0.14% |
66,597
+24,356
| +58% | +$1.43M |
|
139
Nova
NVMI
$7.08B
| $3.9M | 0.14% |
21,963
-14,621
| -40% | -$2.59M |
|
140
Stoneridge
SRI
$227M
| $3.79M | 0.13% |
205,653
-10,685
| -5% | -$197K |
|
141
Hudson Technologies
HDSN
$447M
| $3.75M | 0.13% |
340,852
-245,596
| -42% | -$2.7M |
|
142
Okta
OKTA
$15.8B
| $3.7M | 0.13% |
35,380
-13,726
| -28% | -$1.44M |
|
143
SoundThinking
SSTI
$151M
| $3.7M | 0.13% |
232,800
-155,585
| -40% | -$2.47M |
|
144
Insmed
INSM
$30.3B
| $3.63M | 0.13% |
133,755
-68,438
| -34% | -$1.86M |
|
|
ITCI
145
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $3.46M | 0.12% |
+49,974
| New | +$3.46M |
|
146
Silicon Laboratories
SLAB
$4.3B
| $3.29M | 0.12% |
22,910
-8,675
| -27% | -$1.25M |
|
147
CEVA Inc
CEVA
$520M
| $3.06M | 0.11% |
134,961
-39,782
| -23% | -$903K |
|
148
Sweetgreen
SG
$1.05B
| $3.02M | 0.11% |
+119,441
| New | +$3.02M |
|
|
SAGE
149
DELISTED
Sage Therapeutics
SAGE
| $2.93M | 0.1% |
+156,371
| New | +$2.93M |
|
150
Nextracker
NXT
$9.88B
| $2.92M | 0.1% |
+51,817
| New | +$2.92M |
|